ARCHIVES

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

DCCP Board Approves Concept Of NMR Interintuitional Clinical Research

January 27, 1984

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009